What was the consolidated net profit for FY26?

Consolidated net profit for the year ended March 31, 2026, was ₹2,449 lakhs, representing a 28% increase over the previous year.

Did the auditors raise any concerns?

No. The statutory auditors issued an unmodified opinion on the standalone and consolidated financial results.

How much of the IPO proceeds remains unspent?

As of the filing date, ₹8,131 lakhs of the IPO proceeds remain unutilized.

How did standalone performance compare to consolidated results?

Standalone revenue grew 21% to ₹7,158 lakhs, while consolidated revenue grew at a faster rate of 48% to reach ₹10,436 lakhs.

Earnings · Hospital & Healthcare · Micro cap

Gaudium IVF revenue climbs 48% in consolidated FY26 results

The company reported consolidated revenue of ₹10,436 lakhs for the year ended March 31, 2026, with auditors issuing an unmodified opinion.

— 1 earlier story on Gaudium IVF and Women Health Ltd. →

GAUDIUMIVF By Tipsheet Editorial 29 May 2026 · 11:01 AM IST Verify on BSE · NSE

Mkt cap₹852 cr

P/E44.53×

ROE41.31%

Debt / eq.0.41

₹10,436 lakhs Consolidated revenue for FY26.

What's new

Standalone revenue rose 21% to ₹7,158 lakhs; net profit grew 19% to ₹2,223 lakhs.
Consolidated revenue reached ₹10,436 lakhs, up 48% year-on-year.
IPO proceeds of ₹8,131 lakhs remain unutilized, consistent with the company's post-listing status.

Why this matters

The results track with the company's post-IPO trajectory and contain no surprises. Investors should view this as a routine reporting cycle.

What we're watching

Deployment of the remaining ₹8,131 lakhs in IPO proceeds.
Future margin trends as the company scales its consolidated operations.
Any updates on expansion plans beyond the current financial performance.

The full read

Gaudium IVF and Women Health Ltd. reported its audited financial results for the year ended March 31, 2026. Consolidated revenue reached ₹10,436 lakhs, a 48% increase, while consolidated net profit grew 28% to ₹2,449 lakhs. On a standalone basis, revenue rose 21% to ₹7,158 lakhs with net profit up 19% to ₹2,223 lakhs. The statutory auditors provided an unmodified opinion on the accounts. The company holds ₹8,131 lakhs in unutilized IPO proceeds, which is a standard position for a recent listing. These results align with the company's established growth trajectory and offer no material surprises or changes to guidance. It is a routine filing.

Questions answered

What was the consolidated net profit for FY26?: Consolidated net profit for the year ended March 31, 2026, was ₹2,449 lakhs, representing a 28% increase over the previous year.
Did the auditors raise any concerns?: No. The statutory auditors issued an unmodified opinion on the standalone and consolidated financial results.
How much of the IPO proceeds remains unspent?: As of the filing date, ₹8,131 lakhs of the IPO proceeds remain unutilized.
How did standalone performance compare to consolidated results?: Standalone revenue grew 21% to ₹7,158 lakhs, while consolidated revenue grew at a faster rate of 48% to reach ₹10,436 lakhs.

Mentioned: Gaudium IVF and Women Health Ltd. · FY26 · March 31, 2026

Primary source BSE · NSE

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on GAUDIUMIVF →

29 May 2026 · 11:01 AM IST Gaudium IVF revenue climbs 48% in consolidated FY26 results
1d ago Gaudium IVF revenue climbs 48% as it targets 10 new hubs